The market is segmented based on , By Product (Diagnostic Imaging Systems, Clinical Diagnostic Instruments, Reagents and Consumables), Condition (Neurodegenerative Diseases, Stroke, Epilepsy, Headache Disorders, Sleep Disorders, Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), End User (Hospitals and Surgical Centers, Diagnostic Laboratories and Imaging Centers, Neurology Centers, Ambulatory Care Centers, Research Laboratories and Academic Institutes) – Industry Trends and Forecast to 2029.
.
The Global Neurodiagnostics Market size was valued at USD 7.28 USD Billion in 2021.
The Global Neurodiagnostics Market is projected to grow at a CAGR of 7.3% during the forecast period of 2022 to 2029.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.